HAUS3 and retinoblastoma: For a better understanding of the clinical relevance of SND1-IT1 expression in RB patients, our group divided the 98 RB patients into a high expression group (n = 48) and a low expression group (n = 50), according to the median expression level of SND1-IT1 (7.53) in all RB samples.